NEW YORK ( TheStreet) -- Shares of Apricus Biosciences (Nasdaq: APRI) were gapping down Thursday morning with an open price 16.3% lower than Wednesday's closing price. The stock closed at $4.66 Wednesday and opened today's trading at $3.90. The average volume for Apricus has been 192,500 shares per day over the past 30 days. Apricus has a market cap of $106.9 million and is part of the health care sector and drugs industry. Apricus Biosciences, Inc. engages in the design and development of pharmaceutical products and product candidates based on its patented NexACT drug delivery technology. TheStreet Ratings rates Apricus as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and weak operating cash flow. You can view the full Apricus Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.